Wearables
5 Early-Stage Health Startups Turning Wearable Signals Into Decisions
DealBio tracks early-stage health startups across Europe and North America. These 5 are turning continuous body signals into decisions patients and clinicians can act on.
- Wearables
- Biometric Sensing
- Remote Monitoring
- Digital Health
Continuous measurement is becoming easier, but data alone does not change care. The harder problem is interpretation: turning a stream of signals into something a patient or clinician can act on.
These startups work on different signals and different conditions, yet share the same focus on converting sensing into a decision rather than a dashboard.
At a Glance
- AnoriaUnited States2026Wearable data into daily guidance
- PrecorDxNetherlands2023Heart-failure deterioration signals
- SkaaltecSwitzerland2026Continuous scoliosis brace data
- DXcreteNetherlands2025Sensing for pancreatic function
- Mana MedicalUnited Kingdom2023Activity pacing in arthritis
01
Anoria
Turning wearable data into daily health guidance through an AI companion.
- Country
United States- Founded
- 2026
- Sector
- Consumer health
- Funding stage
- Seed or earlier
- Founders
Why Anoria stands out
Anoria is building on existing consumer wearables rather than new hardware and reports that its AI companion is live with early users.
Founder Robert Hawthorne previously worked on consumer health and data products, and the startup's focus is squarely on interpretation: converting continuous wearable signals into guidance people can act on the same day.
What Anoria is building
Anoria connects to wearables and combines sleep, activity, recovery and other signals into an AI companion that explains what changed and suggests what to do next.
The product is designed to sit on top of devices users already own, so the value comes from interpretation and daily habit support rather than new sensing hardware.
02
PrecorDx
Developing a wearable radio-frequency sensor for home heart-function monitoring.
- Country
Netherlands- Founded
- 2023
- Sector
- Medtech
- Funding stage
- Seed or earlier
Why PrecorDx stands out
PrecorDx combines university-developed radio-frequency sensing with human-study results and founders experienced in cardiovascular research, imaging and commercialization.
The startup has received NWO Take-off and Health~Holland support and has moved into clinical pilot work, giving its home sensing approach a route toward repeated clinical use.
What PrecorDx is building
PrecorDx is developing a wearable radio-frequency system that tracks cardiac and respiratory motion from the chest without repeated blood draws or an implantable sensor.
The purpose of the signal is decision-making: detecting changes associated with worsening heart failure before they become severe enough to require hospital care.
03
Skaaltec
Building sensor technology that measures how scoliosis braces are actually used.
- Country
Switzerland- Founded
- 2026
- Sector
- Medtech
- Funding stage
- Seed or earlier
- Founders
Why Skaaltec stands out
Skaaltec is applying sensing to scoliosis brace treatment, where clinical outcomes depend heavily on how a brace is worn but where objective data has been limited.
The startup’s technology is designed to be added to braces already prescribed to patients, making the measurement part of the existing orthopedic pathway.
What Skaaltec is building
Skaaltec is developing sensors that record brace wear and fit over time and turn that record into information clinicians can review.
The goal is to replace estimated compliance with measured data, so adjustments to treatment can be based on how the brace is actually being used.
04
DXcrete
Developing sensor-based testing for pancreatic function.
- Country
- Netherlands
- Founded
- 2025
- Sector
- Medtech
- Funding stage
- Seed or earlier
- Founders
Why DXcrete stands out
DXcrete is targeting a diagnostic gap where existing pancreatic-function testing is burdensome, aiming instead for a measurement that can be repeated more easily.
Its approach relies on sensing rather than laboratory logistics, which is what makes more frequent measurement realistic for patients and clinicians.
What DXcrete is building
DXcrete is developing sensor-based testing to assess pancreatic function without the complexity of conventional collection-based methods.
The intended output is a clearer, repeatable measurement clinicians can use when deciding on enzyme replacement or further investigation.
Using wearable data to guide daily activity for people with inflammatory arthritis.
- Country
United Kingdom- Founded
- 2023
- Sector
- Digital health
- Funding stage
- Seed or earlier
- Founders
Why Mana Medical stands out
Mana Medical received pre-seed investment from Zinc Ventures and is running an eight-week beta study with recruitment support from the National Rheumatoid Arthritis Society.
The startup uses data from wearables patients already own and converts it into daily pacing guidance and a clinician-facing view of who may need attention first.
What Mana Medical is building
Patients connect an existing wearable and complete a short symptom check-in. Machine learning combines those inputs into personalized activity and pacing guidance.
For clinicians, Mana Medical calculates a Patient Stability Index and ranks enrolled patients by who may need attention, while also preparing monitoring documentation aligned with US Remote Therapeutic Monitoring reimbursement.
Deal Sourcing for Investors
Looking for More Startups Like These?
DealBio helps investment teams discover, research, and monitor early-stage healthcare and life sciences startups aligned with their investment criteria.
Signals only matter when they change a decision
Across these startups, the differentiator is not the sensor but the decision attached to it: what to do today, whether heart failure is worsening, whether a brace is being worn, whether pancreatic function has declined or whether a patient needs rheumatology attention.
For investors, that framing helps separate monitoring products from decision products. Continuous data becomes valuable when someone acts on it, so the startups most likely to stick are those whose output lands in an existing routine with a clear next step.
Methodology
DealBio selected these startups from its database of early-stage health and longevity startups, focusing on businesses that turn wearable or sensor signals into actionable guidance. The selection spans consumer health, cardiology, orthopedics, gastroenterology and rheumatology.
DealBio builds its Startup Briefs using publicly available company materials, ecosystem sources, market references and professional profiles.